StockData
Sanara MedTech Inc. logo

Sanara MedTech Inc. (SMTI) shareholders

SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30144% above fair value
$32.73+0.00 (0.00%)

Close on Nov 18, 2026Market cap $300.72MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
19.4%
2M of 9M shares
Institutional holders
75
16 new, 4 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BAIRD TRUST Co
Joint filing with Baird Financial Corp (8.50%), Baird Financial Group, Inc. (8.50%)
760,2938.50%13G (passive)Dec 31, 2025
The Goldman Sachs Group, Inc.
Joint filing with Goldman Sachs & Co. LLC (5.00%)
462,0215.00%13G (passive)Sep 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of SMTIValueChange% of portfolio
BlackRock, Inc.248,8272.71%$5.87M+20,0600.00%
Vanguard Capital Management LLC194,8972.12%$4.60M+43,5300.00%
Royal Bank of Canada130,9951.43%$3.09M−3940.00%
Stonebridge Wealth Management, LLC129,4521.41%$3.05M−7,4472.73%
Aqr Capital Management LLC112,2071.22%$2.65M+72,2690.00%
Geode Capital Management, LLC89,1790.97%$2.10M+3,5170.00%
Goldman Sachs Group Inc74,1980.81%$1.75M+52,6130.00%
Renaissance Technologies LLC67,4000.73%$1.59M+2,7200.00%
State Street Corp63,4690.69%$1.50M+7800.00%
Squarepoint Ops LLC53,8110.59%$1.27M−19,7960.00%
Jane Street Group, LLC50,8060.55%$1.20M+12,2220.00%
Marshall Wace, Llp49,4570.54%$1.17M−26,8250.00%
Citadel Advisors LLC36,8130.40%$868.42K+5,7000.00%
Northern Trust Corp36,4410.40%$859.64K+3,1850.00%
Jacobs Levy Equity Management, Inc31,6440.34%$746.48KNew0.00%
Walleye Capital LLC30,4650.33%$718.67KNew0.00%
Los Angeles Capital Management LLC26,8300.29%$632.92KNew0.00%
Vanguard Fiduciary Trust Co26,0270.28%$613.98K+6520.00%
Evernest Financial Advisors, LLC25,7000.28%$606.26KNew0.13%
Morgan Stanley23,6280.26%$557.38K+3,9880.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026752M19.4%16 / 3215 / 40M0M
Q1 2026651M16.2%18 / 2614 / 51M1M
Q4 2025532M21.2%9 / 2313 / 111M0M
Q3 2025581M12.5%13 / 1222 / 70M0M
Q2 2025521M12.4%8 / 1719 / 50M0M
Q1 2025491M10.0%4 / 1220 / 60M0M
Q4 2024511M10.4%9 / 245 / 20M0M
Q3 2024441M8.9%8 / 1510 / 30M0M
Q2 2024401M8.0%4 / 2010 / 70M0M
Q1 2024431M7.6%1 / 1420 / 40M0M
Q4 2023471M7.6%4 / 2113 / 00M0M
Q3 2023431M6.9%5 / 1115 / 90M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

79 funds held SMTI in Q2 2026, 70% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of SMTIValue% of fundAs of
Vanguard Total Stock Market Index Fund148,8991.62%$3.51M0.00%Jun 30, 2026
iShares Russell 2000 ETF74,6820.81%$1.76M0.00%Jun 30, 2026
Vanguard Extended Market Index Fund42,8650.47%$1.01M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund36,3500.40%$1.23M0.00%Jul 31, 2026
iShares Russell 2000 Growth ETF31,6680.34%$747.05K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund19,5250.21%$444.97K0.00%May 31, 2026
Vanguard Russell 2000 Index Fund15,5240.17%$353.79K0.00%May 31, 2026
iShares Micro-Cap ETF11,2300.12%$264.92K0.02%Jun 30, 2026
U.S. Small Cap Equity Fund11,0380.12%$373.75K0.04%Jul 31, 2026
Goldman Sachs Absolute Return Tracker Fund9,6090.10%$226.68K0.00%Jun 30, 2026
Schwab Small-Cap Index Fund8,3450.09%$282.56K0.00%Jul 31, 2026
Fidelity Total Market Index Fund6,5290.07%$148.80K0.00%May 31, 2026
Fidelity Series Total Market Index Fund5,7160.06%$130.27K0.00%May 31, 2026
Master Small Cap Index Series5,1910.06%$122.46K0.00%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund5,1770.06%$117.98K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Seth D. YonChief Executive Officer, Director105,8851.15%Sep 16, 2026
Ashley M. MackeyController4,9670.05%May 5, 2026
Jacob A. WaldropChief Operating Officer24,3770.27%Apr 16, 2026
Elizabeth B. TaylorChief Financial Officer17,6320.19%Mar 23, 2026
Michael D. McNeilCh. Acct. & Ch. Admin. Officer28,5870.31%Aug 19, 2025
Suresh V. MuppallaPres & CEO, Tissue Health Plus2,9730.03%Apr 15, 2025
Robert Andrew DeSutterDirector28,7400.31%Jun 5, 2026
Roszell Mack IIIDirector21,8420.24%Jun 5, 2026
Eric D. MajorDirector14,2320.15%Jun 5, 2026
Keith G. MyersDirector9,3250.10%Jun 5, 2026
Eric D. TanzbergerDirector22,9660.25%Jun 5, 2026
Ronald T. NixonDirector, 10% owner1,032,05211.23%Jun 5, 2026
Ann Beal SalamoneDirector26,8580.29%Jun 5, 2026
Sara N. OrtweinDirector25,4150.28%Jun 5, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Seth D. Yon
Chief Executive Officer, Director
Sep 15, 2026Tax withholding−3,661$35.11$128.54K105,885
Ann Beal Salamone
Director
Jun 4, 2026Award+4,154––26,858
Keith G. Myers
Director
Jun 4, 2026Award+4,385––9,325
Robert Andrew DeSutter
Director
Jun 4, 2026Award+5,539––28,740
Eric D. Major
Director
Jun 4, 2026Award+4,846––14,232
Roszell Mack III
Director
Jun 4, 2026Award+5,308––21,842
Ronald T. Nixon
Director, 10% owner
Jun 4, 2026Award+4,154––68,196
Eric D. Tanzberger
Director
Jun 4, 2026Award+5,308––22,966
Sara N. Ortwein
Director
Jun 4, 2026Award+4,616––25,415
Seth D. Yon
Chief Executive Officer, Director
May 15, 2026Tax withholding−3,852$21.06$81.12K109,546
Jacob A. Waldrop
Chief Operating Officer
Apr 15, 2026Tax withholding−378$20.01$7.56K24,377
Ashley M. Mackey
Controller
Mar 22, 2026Award+2,804––4,967
Ashley M. Mackey
Controller
Mar 22, 2026Award−2,804––5,067
Elizabeth B. Taylor
Chief Financial Officer
Mar 22, 2026Award−12,687––17,632
Seth D. Yon
Chief Executive Officer, Director
Mar 22, 2026Award−25,430––113,398
Jacob A. Waldrop
Chief Operating Officer
Mar 22, 2026Award−13,956––24,755
Seth D. Yon
Chief Executive Officer, Director
Mar 7, 2026Tax withholding−596$18.87$11.25K87,968
Seth D. Yon
Chief Executive Officer, Director
Mar 1, 2026Tax withholding−414$20.44$8.46K88,564
Seth D. Yon
Chief Executive Officer, Director
Mar 1, 2026Tax withholding−491$20.44$10.04K88,487
Seth D. Yon
Chief Executive Officer, Director
Feb 25, 2026Tax withholding−873$19.90$17.37K88,978
Ashley M. Mackey
Controller
Feb 25, 2026Tax withholding−149$19.90$2.97K2,263
Elizabeth B. Taylor
Chief Financial Officer
Feb 25, 2026Tax withholding−437$19.90$8.70K4,945
Jacob A. Waldrop
Chief Operating Officer
Feb 25, 2026Tax withholding−714$19.90$14.21K10,799
Seth D. Yon
Chief Executive Officer
Sep 15, 2025Award+28,563––89,851
Michael D. McNeil
Ch. Acct. & Ch. Admin. Officer
Aug 19, 2025Tax withholding−2,324$30.86$71.72K28,587
Eric D. Tanzberger
Director
May 22, 2025Award+3,590––17,658
Sara N. Ortwein
Director
May 22, 2025Award+3,277––20,799
Keith G. Myers
Director
May 22, 2025Award+2,965––4,940
Robert Andrew DeSutter
Director
May 22, 2025Award+3,746––23,201
Eric D. Major
Director
May 22, 2025Award+3,277––9,386
Ann Beal Salamone
Director
May 22, 2025Award+2,809––22,704
Roszell Mack III
Director
May 22, 2025Award+3,433––16,534
Seth D. Yon
Pres. & Ch. Commercial Officer
May 15, 2025Tax withholding−4,929$30.88$152.21K61,288
Jacob A. Waldrop
Chief Operating Officer
Apr 15, 2025Tax withholding−378$29.38$11.11K11,513
Michael D. McNeil
Ch. Acct. & Ch. Admin. Officer
Apr 10, 2025Tax withholding−378$33.01$12.48K31,273
Michael D. McNeil
Ch. Acct. & Ch. Admin. Officer
Apr 10, 2025Tax withholding−343$34.69$11.90K31,651
Michael D. McNeil
Ch. Acct. & Ch. Admin. Officer
Apr 10, 2025Tax withholding−527$34.69$18.28K31,994
Michael D. McNeil
Ch. Acct. & Ch. Admin. Officer
Apr 10, 2025Tax withholding−362$34.65$12.54K30,911
Michael D. McNeil
Ch. Acct. & Ch. Admin. Officer
Mar 19, 2025Award+1,486––32,521
Elizabeth B. Taylor
Chief Financial Officer
Feb 25, 2025Award+5,382––5,382
Ronald T. Nixon
Chief Executive Officer, Director, 10% owner
Feb 25, 2025Award+7,534––64,042
Jacob A. Waldrop
Chief Operating Officer
Feb 25, 2025Award+8,790––11,891
Michael D. McNeil
Ch. Acct. & Ch. Admin Officer
Feb 25, 2025Award+5,037––31,035
Keith G. Myers
Director
Nov 11, 2024Award+1,975––1,975
Eric D. Tanzberger
Director
Jun 12, 2024Award+3,768––14,068
Ronald T. Nixon
Chief Executive Officer, Director, 10% owner
Jun 12, 2024Award+10,812––56,508
James W. Stuckert
Director, 10% owner
Jun 12, 2024Award+3,440––840,218
Roszell Mack III
Director
Jun 12, 2024Award+3,604––13,101
Ann Beal Salamone
Director
Jun 12, 2024Award+2,949––19,895
Sara N. Ortwein
Director
Jun 12, 2024Award+3,440––17,522
Robert Andrew DeSutter
Director
Jun 12, 2024Award+3,932––19,455
Eric D. Major
Director
Jun 12, 2024Award+3,440––6,109
Jacob A. Waldrop
Chief Operating Officer
Apr 15, 2024Award+3,101––3,101
Michael D. McNeil
Chief Financial Officer
Mar 7, 2024Award+4,650––25,998
Zachary B. Fleming
Chief Executive Officer
Mar 7, 2024Award+12,693––48,854
Michael D. McNeil
Chief Financial Officer
Mar 1, 2024Tax withholding−687$38.96$26.77K21,947
Michael D. McNeil
Chief Financial Officer
Mar 1, 2024Tax withholding−599$38.96$23.34K21,348
Zachary B. Fleming
Chief Executive Officer
Mar 1, 2024Tax withholding−926$38.96$36.08K36,951
Zachary B. Fleming
Chief Executive Officer
Mar 1, 2024Tax withholding−790$38.96$30.78K36,161
Zachary B. Fleming
Chief Executive Officer
Feb 1, 2024Tax withholding−427$33.72$14.40K37,877

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
5.27%
0M shares short
Days to cover
3.2
At 0M shares a day
Change since last report
+10.0%
From 0M shares
Short volume, 20 days
58.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Sanara MedTech's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,955 shares on Aug 31, 2026 over the last 90 days.

See a number that looks wrong?